Keytruda and Vancomycin hydrochloride drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Keytruda (pembrolizumab) and Vancomycin hydrochloride (vancomycin hydrochloride). Common drug interactions include biloma among females and disseminated intravascular coagulation among males.
The phase IV clinical study analyzes what interactions people have when they take Keytruda and Vancomycin hydrochloride. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.
What is Keytruda?
Keytruda has active ingredients of pembrolizumab. It is often used in renal cell carcinoma. eHealthMe is studying from 57,404 Keytruda users. Check the latest studies of Keytruda.
What is Vancomycin hydrochloride?
Vancomycin hydrochloride has active ingredients of vancomycin hydrochloride. It is often used in mrsa infection. eHealthMe is studying from 8,399 Vancomycin hydrochloride users. Check the latest studies of Vancomycin hydrochloride.
13 people who take Keytruda and Vancomycin hydrochloride together, and have interactions are studied.

What are the common drug interactions of Keytruda and Vancomycin Hydrochloride, by gender? *:
female:
- Biloma (extrabiliary collection of bile)
- Malignant neoplasm progression (cancer tumour came back)
- Tumour associated fever (fever because of tumour)
- Febrile neutropenia (fever with reduced white blood cells)
- Diarrhoea
- Pyrexia (fever)
- Rash
- Rectal haemorrhage (bleeding from anus)
- Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin)
- Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
male:
- Disseminated intravascular coagulation (systemic activation of blood coagulation)
- Malignant neoplasm progression (cancer tumour came back)
- Pyrexia (fever)
- Small intestinal haemorrhage (bleeding from small intestine)
- Brain oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain)
- Hepatic enzyme increased
- Nephritis (inflammation of the nephrons in the kidneys)
- Urticaria (rash of round, red welts on the skin that itch intensely)
- Adverse event
- Bacterial infection
What are the common drug interactions of Keytruda and Vancomycin Hydrochloride, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Febrile neutropenia (fever with reduced white blood cells)
- Pyrexia (fever)
- Rash
50-59:
- Febrile neutropenia (fever with reduced white blood cells)
- Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin)
- Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
60+:
- Disseminated intravascular coagulation (systemic activation of blood coagulation)
- Bacterial infection
- Pyrexia (fever)
- Small intestinal haemorrhage (bleeding from small intestine)
- Brain oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain)
- Hepatic enzyme increased
- Nephritis (inflammation of the nephrons in the kidneys)
- Urticaria (rash of round, red welts on the skin that itch intensely)
- Diarrhoea
- Rectal haemorrhage (bleeding from anus)
What are the existing conditions these people have? *
- Fever: 5 people, 38.46%
- Type 2 Diabetes: 4 people, 30.77%
- Lung Adenocarcinoma Stage Iv (the cancer has spread to other organs of the body, such as the other lung, brain, or liver): 4 people, 30.77%
- Blood Beta-D-Glucan Increased: 4 people, 30.77%
- Cancer Pain: 4 people, 30.77%
- Disseminated Intravascular Coagulation (systemic activation of blood coagulation): 4 people, 30.77%
- Interstitial Lung Disease: 4 people, 30.77%
- Hypoalbuminaemia (levels of albumin in blood serum are abnormally low): 4 people, 30.77%
- Pancreatitis (inflammation of pancreas): 3 people, 23.08%
- Gastroenteritis Staphylococcal (inflammation of stomach and intestine caused by staphylococcal infection): 3 people, 23.08%
* Approximation only. Some reports may have incomplete information.
Do you take Keytruda and Vancomycin hydrochloride?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Keytruda (57,404 reports)
- Vancomycin hydrochloride (8,399 reports)
Browse all drug interactions of Keytruda and Vancomycin hydrochloride:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Keytruda:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Vancomycin hydrochloride:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Keytruda and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Vancomycin hydrochloride and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on pembrolizumab and vancomycin hydrochloride (the active ingredients of Keytruda and Vancomycin hydrochloride, respectively), and Keytruda and Vancomycin hydrochloride (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Depakote Er cause Urinary Incontinence Aggravated? - 2 seconds ago
- Drug interactions of Fish Oil and Pemetrexed - 5 seconds ago
- Could Carbamazepine cause Cough? - 12 seconds ago
- Could Decadron cause Glycosylated Haemoglobin Increased? - 15 seconds ago
- Drug interactions of Fish Oil and Requip Xl - 17 seconds ago
- Drug interactions of Nuvigil and Ezetimibe - 26 seconds ago
- Drug interactions of Allegra and Magnevist - 26 seconds ago
- Could Coenzyme Q10 cause Renal Injury? - 31 seconds ago
- Drug interactions of Losartan and Psyllium - 33 seconds ago
- Could Profen cause Conjunctival Disorder? - 39 seconds ago